Category: Cannabis Stocks
Leave a Comment on ‘Devastating’: Retired firefighter says he lost most of his retirement savings investing in stocks that were targeted by a famous short-seller
‘Devastating’: Retired firefighter says he lost most of his retirement savings investing in stocks that were targeted by a famous short-seller
He turned $110K into $190K, then watched his savings vanish after public criticism from from Citron Research’s Andrew Left.
Leave a Comment on Retired firefighter says he lost most of his savings investing in stocks that were targeted by famous short-seller
Retired firefighter says he lost most of his savings investing in stocks that were targeted by famous short-seller
He turned $110K into $190K, then watched his savings vanish after public criticism from from Citron Research’s Andrew Left.
Canopy Growth’s Stock Just Dropped — Here’s Why I’m Still Not Buying
For anyone who has observed Canopy Growth (NASDAQ: CGC) during the past few years, it won’t be shocking to learn…
Auxly Cannabis is still undervalued, this analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $0.25 target on Auxly Cannabis Group (Auxly Cannabis Group Stock Quote,…
Buy this cannabis stock for a double, analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $3.25 target on Organigram Holdings (Organigram Global Stock Quote, Chart, News,…
Is Canopy Growth Stock Finally Setting Up for a Real Turnaround?
Canopy Growth (NASDAQ: CGC) has made considerable efforts to turn itself around. Over the past few years, the Canada-based cannabis…
Leave a Comment on Canopy Growth Is One of the Market’s Most Polarizing Stocks: 3 Scenarios for the Next 12 Months
Canopy Growth Is One of the Market’s Most Polarizing Stocks: 3 Scenarios for the Next 12 Months
After years of heavy losses and repeated restructurings, Canopy Growth is showing early signs of stabilization.
Leave a Comment on Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)
Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)
Organigram reported weaker second-quarter revenue and profitability as vape and infused pre-roll sales slowed, while the company positioned its Sanity…
This weed stock is undervalued, analyst says
The analyst expects Trulieve to generate Adjusted EBITDA of US$401.1-million on revenue of US$1.178-billion in fiscal 2026, improving to US$415.8-million…
Here’s why Tilray Brands stock has crashed after cannabis reclassification
Tilray Brands stock price crashed to its lowest level since August last year despite the recent US policy change that…


Recent Comments